ISM-TEC & Sesneber International are authorized exclusive distributors for all IGEA products in Saudi Arabia.
In Saudi Arabia, please contact our local office at the address listed below for quotes and additional information.
Sesneber International
P. O. Box 87437
Riyadh 11642, Saudi Arabia
Phone: +966-1-454-1222
Fax: +966-1-453-7890
E-mail:
info @ sesneberinternational . com
Area Specialist: M. Ahmad Ali
Phone: +966-50-693-2324
E-mail: mirahmadali @ ism-tec . com
All information displayed on this page is provided courtesy of IGEA. Cliniporator™, DBM Sonic Bone Profiler™, Biostim™, Osteobit™, Osteospine™, FAST™ and I-ONE™ are all trademarks of IGEA, Italy.
IGEA founded its activity in 1980, with the aim of expanding the study and employment of non-ionizing physical energy in the medical field.
The interface between physics and clinics, biophysics, is the context in which IGEA has proved itself in these years, promoting research projects targeted on the creation of innovative and effective solutions for diagnosis and treatment.
Diagnostics
DBM Sonic Bone Profiler ™
DBM Sonic Bone Profiler™ is the only ultrasound device that applies the method of signal analysis in transmission through phalanges. This technique of clinical investigation has proven to be particularly effective in postmenopausal osteoporosis: for screening, diagnosis and therapies monitoring.
Bone tissue at the phalanx shows the highest sensibility to bone resorption occurring at the menopause.
Learn more about the DBM Sonic Profiler™ by visiting the respective product pages at IGEA's website:
Biostim™ (pulsed electromagnetic fields), Osteobit™, Osteospine™ (electric fields) and FAST™ (ultrasounds) represent effective instruments for the Orthopaedist to enhance the osteogenetic effect without requiring any further surgery, cutting the time of functional recovery.
I-ONE™, latest generation device, has been created with a specific attention to treatment adherence. Portable, battery sourced, is an innovating therapeutic system of biophysical chondroprotection for the cartilage.
I-ONE™, after arthroscopic surgery (anterior cruciate ligament reconstruction), was able to cut by half the time of functional recovery and dramatically reduced the NSAIDs use. The C.R.E.S. Study, that showed these impressive results, received the award of excellence by the American Academy of Orthopaedic Surgeons.